Results 231 to 240 of about 33,714 (244)

CCR5 promoter polymorphism and HIV-1 disease progression

Lancet, The, 1998
David Mcdermott, Philip Murphy, Peter Zimmerman   +2 more
exaly  

Advances of CCR5 antagonists: From small molecules to macromolecules

European Journal of Medicinal Chemistry, 2020
Shiyuan Liu, Jianyou Shi
exaly  

Epigenetic mechanisms, T-cell activation, andCCR5genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor

Proceedings of the National Academy of Sciences of the United States of America, 2015
Steven G Deeks, Caroline Tiemessen, Liudmyla Shostakovych-Koretskaya   +2 more
exaly  

Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist

Brain, Behavior, and Immunity, 2020
Stephanie Cicalese, Scott M Rawls
exaly  

CCR5 as a Treatment Target in Pulmonary Arterial Hypertension

Circulation, 2014
Serge Adnot, Mark Gladwin, Marion Delcroix   +2 more
exaly  

CCR5: A Receptor at the Center Stage in Infection

2022
openaire   +1 more source

Negative association between the chemokine receptor CCR5-Δ32 polymorphism and rheumatoid arthritis: a meta-analysis

Genes and Immunity, 2006
Sampath Prahalad
exaly  

CCR5Δ32 genotype is associated with outcome in type 2 diabetes mellitus

Diabetes Research and Clinical Practice, 2009
Daan Ties, Henk Bilo, Gijs Landman
exaly  

CCR5: From Natural Resistance to a New Anti-HIV Strategy

Viruses, 2010
Lucia Lopalco, Lopalco Lucia
exaly  

Association of CCR5 ▵32 with reduced risk of asthma

Lancet, The, 1999
Ian Hall, Peter J Helms, A Wheatley
exaly